Business · 13/01/1994Updated: 10/15/2026 · 1 min read

Opportunity for a License for Nonpatented Material

The Centers for Disease Control and Prevention (CDC) is offering a license for recombinant proteins and synthetic peptides to be used as immunodiagnostic reagents for detecting Hepatitis C Virus (HCV) antibodies.